|45.97||-0.03 / -0.07%|
As of 3:59pm ET
|46.00||+0.03 / +0.07%|
The 6 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 46.00, with a high estimate of 51.00 and a low estimate of 37.00. The median estimate represents a +0.07% increase from the last price of 45.97.
The current consensus among 7 polled investment analysts is to Hold stock in Hyperion Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.